3 stories mentioning IPSCUpdated 25d ago
Every FINWIRES story that references IPSC, newest first.
Century Therapeutics (IPSC) has an average rating of buy and mean price target of $5.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
(Updates to add price target.)Century Therapeutics (IPSC) has an average rating of buy and mean price target of $5.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Century Therapeutics (IPSC) has an average rating of buy and mean price target of $5.12, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
